Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2220247 | 1.00 | IDO1 (0.33) | IDO1 | |
| SCHEMBL16869606 | 0.78 | CHRNB2 (0.30) | — | |
| SCHEMBL10791781 | 0.70 | IDO1 (0.31) | IDO1 | |
| SCHEMBL6208777 | 0.68 | CYP11B1 (0.46) | IDO1 | |
| SCHEMBL16091249 | 0.67 | — | — | |
| SCHEMBL1474330 | 0.65 | TBXAS1 (0.45) | — | |
| SCHEMBL2219288 | 0.63 | TBXAS1 (0.45) | — | |
| SCHEMBL21120748 | 0.62 | ALDH1A1 (0.37) | IDO1 | |
| SCHEMBL9597203 | 0.61 | — | — | |
| SCHEMBL730978 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216312-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-8592498-B2 | Method for producing organic compound and organic compound obtained by the method | M. TECHNIQUE CO., LTD. (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | M. TECHNIQUE CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| EP-2216312-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE SAME | M Technique Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-7179925-B2 | Method for reducing organic compounds in microreactor by means of hydrides and/or the derivatives thereof | MERCK PATENT GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-20040225157-A1 | Method for reducing organic compounds in microreactor by means of hydrides and/or the derivatives thereof | MERCK PATENT GMBH (DE) | 2004-11-11 | — | — | US | disclosed |
| EP-1265828-A1 | METHOD FOR REDUCING ORGANIC COMPOUNDS IN A MICROREACTOR BY MEANS OF HYDRIDES AND/OR THE DERIVATIVES THEREOF | MERCK PATENT GmbH (DE) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001070649-A1 | METHOD FOR REDUCING ORGANIC COMPOUNDS IN A MICROREACTOR BY MEANS OF HYDRIDES AND/OR THE DERIVATIVES THEREOF | MERCK PATENT GMBH (DE) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | OR10J3, PORCN, ABCG2 | IDO1 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.